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Abstract
Background: We developed and evaluated a tailored programme to implement three evidence-based
recommendations for multimorbid patients with polypharmacy into primary care practices: structured medication
counselling including brown bag reviews, the use of medication lists and medication reviews. No effect on the primary
outcome was found. This process evaluation aimed to identify factors associated with outcomes by exploring nine
hypotheses specified in the logic model of the tailored programme.
Methods: The tailored programme was developed with respect to identified determinants of practice and consisted of
a workshop for practice teams, elaboration of implementation action plans, aids for medication reviews, a multilingual
info-tool for patients on a tablet PC, posters and brown paper bags as reminders for patients. The tailored programme
was evaluated in a cluster randomized trial. The process evaluation was based on various data sources: interviews with
general practitioners and medical assistants of the intervention group and a survey with general practitioners of the
intervention and control group, written reports on the implementation action plans, documentation forms for
structured medication counselling and the log file of the info-tool.
Results: We analyzed 12 interviews, 21 questionnaires, 120 documentation forms for medication counselling, 5
implementation action plans and one log file of the info-tool. The most frequently reported effect of the tailored
programme was the increase of awareness for the health problem and the recommendations, while implementation
of routine processes was only reported for structured medication counselling. The survey largely confirmed the
usefulness of the applied strategies, yet the interviews provided a more detailed understanding of the actual use
of the strategies and several suggestions for modifications of the tailored programme.
Conclusions: The tailored programme seemed to have induced awareness as a first step of behaviour change.
Several modifications of the tailored programme may enhance its effectiveness such as conducting outreach
visits instead of a workshop, improved targeting, provision of evidence, integration of tools into the practice
software and information materials in tailored formats.
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Background
Current care and best practice
Patients with multiple chronic conditions and polyphar-
macy are at high risk for preventable adverse drug reac-
tions (ADR) [1], potentially avoidable hospital admissions
and preventable deaths [2, 3]. The risk factors and causes
leading to such undesired events are well described [4–6]
and frequently involve the challenge of coordinating the
care of this patient group among different health care pro-
viders and prescribers. Thus, general practitioners (GPs),
who act as coordinators and central medical care pro-
viders in the health system, play an important role in the
care of multimorbid patients with polypharmacy, espe-
cially in Germany, a country without formal gate-keeping
system and free access to specialist care [7].
Therefore, it is important to optimize medication-
related processes in general practices when trying to
improve the care of these patients [8]. We identified
three recommendations from the literature, which were
later on also included into a German guideline on mul-
timedication in elderly primary care patients [9]. We
developed and evaluated a tailored programme (TP) to
improve the implementation of recommendations,
which address different areas of care:
 Recommendation A on communication about
medication: All patients with polypharmacy and
additional risk factors for medication problems should
receive structured medication counselling (SMC)
at least once per year. Beside medication-related
information, SMC comprises a complete inventory of
the medication actually taken by the patient (so called
“brown bag review”) and an assessment of adherence
and possible application problems. A separate ap-
pointment should be planned for SMC [9, 10].
 Recommendation B on documentation of medication:
All patients with polypharmacy should take along
an updated, complete and comprehensible
medication list, concordant with the template of
the Drug Commission of the German Medical
Association [11].
 Recommendation C on prescribing: Physicians should
perform structured medication reviews with the aid of
tools, such as the PRISCUS list [12] or the Medication
appropriateness index (MAI) [13], to reduce
potentially inappropriate medication regimes.
PRISCUS lists 83 substances which should be avoided
in older, multimorbid patients. The MAI is a
compilation of implicit criteria which should be taken
into account when reviewing a medication regimen.
Tailoring
Interventions to improve the appropriate use of poly-
pharmacy frequently do not show clinically significant
effects and are criticized for the lack of guidance on
intervention development and reporting [14, 15]. “Tai-
loring” is an approach to increase the effectiveness of
interventions by systematic identification of barriers
and enablers of practice (also referred to as “determi-
nants of practice”) and careful selection of strategies to
address these determinants [16].
The term tailoring has to be distinguished from
“modification” and “adaptions” of interventions. While
tailoring refers to the development of the interventions
in the design phase, “modifications can include adapta-
tions, which are planned or purposeful changes to the
design or delivery of an intervention, but they can also
include unintentional deviations from the interventions
as originally designed. That is, some modifications occur
with the intention to retain fidelity to the fundamental
elements or spirit of the intervention, whereas others
may be unplanned changes made in reaction to a spe-
cific circumstance” [17].
This study is part of the “Tailoring Interventions for
Chronic Diseases” (TICD) project [18], during which five
TPs for implementation of recommended practices have
been developed and evaluated in randomized controlled
trials [19–23]. The process of tailoring used in TICD has
been described in detail elsewhere [24–26] and com-
prised the systematic identification of determinants and
strategies involving qualitative and quantitative methods
and various target groups. In our study, GPs, specialists,
nurses and researchers were targeted to identify determi-
nants and strategies. The final selection of determinants
and strategies was done by the researchers. A “logic
model” which illustrates the assumed mechanisms of the
TP and the assumed relation between the selected strat-
egies, the determinants intended to be modified, the rec-
ommendations intended to implement and the effect on
health outcomes was elaborated for each TP (Fig. 1).
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Strategies to implement recommendations on
polypharmacy
The TP of our trial consisted of the following strategies
[22]: The intervention period started with a four-hour
workshop for practice teams, delivered by two of the au-
thors (CJ, JS). It comprised an analysis of barriers and so-
lutions for the implementation of the recommendations
using a card technique, role plays and case examples to
convey pharmacological skills and knowledge as well as
organizational information related to the study. Details
about the workshop have been published separately [27].
At the end of the workshop, the participants received in-
formation materials for patients (posters, brown bags and
a multilingual info-tool on a tablet PC). After the work-
shop, the participants were asked to organize a team
meeting to elaborate “implementation action plans”, i.e. an
individual concept of how they were going to implement
the recommendations into their practice. They were asked
to send a written report about their decisions to the study
centre. Furthermore, the intervention and control group
was provided with a list of patients meeting the inclusion
criteria derived from insurance claim data.
Effectiveness of the tailored programme
Despite the comprehensive identification of determinants
and strategies prior to designing the TP, we did not
observe an effect of the TP on the primary outcome,
which was a combination of ten indicators reflecting the
degree of implementation. Only two indicators measuring
the implementation of SCM increased significantly in the
intervention group, and the item “I show my medication
list regularly when buying a drug in the pharmacy” of a
questionnaire measuring patients’ self-reported use of the
medication list improved significantly in the intervention
group. Yet due to limitations of the trial (e.g. sample size
not reached), results have to be interpreted carefully [28].
The process evaluation presented in this article ex-
plores the following nine hypotheses—which had been
specified in the logic model during the design phase of
the intervention (Fig. 1)—in order to explain the low ef-
fectiveness and to provide suggestions for modification
of the programme:
1. Training increased expert knowledge and routines
2. Implementation action plans increased routine
3. Patient lists helped to identify suitable patients for
SMC
4. The checklist helped to establish routines for SMC
in the practice
5. The aids for medication reviews increased expert
knowledge and feasibility of instruments for
systematic medication reviews
Fig. 1 Logic model of the tailored programme. The figure describes the assumed mechanism of the intervention and the structure of the
evaluation: An implementation programme consisting of various strategies to address specific determinants of practice will increase the
implementation of evidence-based recommendations. Based on previous evidence, it can be assumed that increased implementation will result
in improve health outcomes. Therefore, the primary outcome is the “degree of implementation” while the effects of the recommendations are
secondary outcomes. The relevance and modification of determinants and the use and helpfulness of the strategies are subject of the
process evaluation.
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6. The template helped to bring medication lists in line
with the standards
7. The information material for patients increased the
self-management abilities of patients and reduced
language barriers and difficulties of comprehension
8. Implementation of the recommendations has
improved
9. Implementation of the recommendations leads to
improved health outcomes
Methods
Study design
The outcomes of the TP have been evaluated in a clus-
ter randomized controlled trial with a follow-up time of
9 months and randomization on the level of quality cir-
cles (registration number ISRCTN 34664024). The de-
sign and evaluation of primary and secondary outcomes
have been described separately [28]. This article focuses
on the process evaluation of the trial for which a mixed
method design based on interviews and a survey with
the participating health care professionals was used.
While all research questions of the survey were also
part of the interviews in order to compare the re-
sponses, the interviews covered additional aspects (e.g.
the question about alternative strategies) not asked in
the survey. It followed a previously published study
protocol which guided the TICD trials [26].
Sample
The TP was delivered to primary care practices in one
larger area in South Germany that participated in a spe-
cial care contract of one large German health insurance
(HZV AOK Baden-Württemberg) [29] and in “quality
circles” comprising small group meetings of GPs of one
local area [30]. The inclusion criteria for patients were
age >50 years, diagnosis of at least three chronic condi-
tions based on a previously published diagnosis list [31],
repeated prescription of four different drugs, high risk
for ADR according to the subjective assessment of the
treating GP and mental and physical ability to partici-
pate in the study. The target group for this study were
GPs for interviews and the survey and MA for
interviews.
Data collection
The intervention period started in the end of January
2014 with the workshop and ended in October 2014
with the closure of the data bank for medication
counselling.
We conducted a survey with GPs of the interven-
tion and control group which was completed in the
practices on the provided tablet PC and delivered to
a secure server of the University of Heidelberg within
2 months after the intervention period had ended. It
focused on the relevance and modification of determi-
nants and the usefulness and modification of strat-
egies. Parts of the survey were applied to the
intervention and control group and parts to the inter-
vention group only (Table 1).
Furthermore, we conducted individual interviews
with GPs and medical assistants (MA) of the inter-
vention group shortly before the intervention period
ended from end of August to end of September 2014.
In group practices, only one GP and one MA were
interviewed to limit the effort for each practice. The
decision which GP/MA would do the interview was
taken by the participants. Interviews were done in the
practices by a researcher not directly involved in the
delivery of the TP. They followed a semi-structured
interview guide focusing on the following key
questions:
– What is the participants’ view of the
recommendations on polypharmacy?
– How did the participants use the strategies offered
to them?
– How did the participants evaluate the feasibility
and helpfulness of the applied strategies?
– Did the strategies from their perspective help to
modify the determinants as intended?
– How successful was the implementation of the
recommendations from the perspective of the
participants?
Furthermore, we asked the practice teams to send us a
written report about the implementation action plan
they had elaborated latest 2 weeks after the workshop.
We asked all GPs to document each SMC they con-
ducted via an online form on the tablet PC. Additionally,
we analyzed the log file of the tablet PC to assess how
often the info-tool was used.
Data analysis
Interviews were audiotaped, transcribed and analyzed
independently by two researchers according to the
principles of qualitative content analysis [32]. The re-
search questions described above served as deductive
framework to which sub-categories were added induct-
ively by two researchers. The coding was discussed
among the researchers and the classification system
was adapted continuously. After the analysis of the last
interview, a final version of the classification system
was developed and the assignment of the quotations
was checked for consistency. The survey, the forms for
the documentation of SMC and the log file were ana-
lyzed descriptively. The implementation action plans
were summarized.
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Results
Participants
We enrolled 22 GPs from 18 practices and 344 patients
into the study. In the intervention group, 143 patients and
10 GPs from 6 practices and in the control croup, 130 pa-
tients and 11 GPs from 11 practices completed the study.
Patients were on average 72 (52-94) years old, diagnosed
with 5.7 chronic diseases and prescribed 7.3 drugs. GPs
were on average of 55 (44–68) years old and by the major-
ity male (82%, n = 18). The fact that several GPs of the
intervention group worked in group practices and all GPs
of the control group in single practices is a result of the
randomization on quality circle level and a limitation of
the study. In total, 12 interviews were conducted which
lasted on average 32 min (16–58). All participating GPs
(n = 21) completed the survey. We received written re-
ports on the implementation action plans from five out of
six practices. In total, 120 forms for SMC were completed
by GPs of the intervention group.
Hypotheses of the logic model
The logic model of the TP (Fig. 1) specifies nine main
hypotheses which we will deal with consecutively
Table 1 Survey on determinants and strategies
Item
number
Survey item Group Agree
% (n)
Partly
agree
% (n)
Do not
agree
% (n)
1 (a) I need more knowledge
to implement these
recommendations into
my practice
IG +
CG
14.3
(3)
57.1
(12)
28.6
(6)
IG 20.0
(2)
60.0
(6)
20.0
(2)
CG 9.1
(1)
54.5
(6)
36.4
(4)
1 (b) The workshop of the PomP
study conveyed useful
knowledge for the
implementation of the
recommendations into
my practice
IG 60.0
(6)
40.0
(4)
0.0
(0)
2 (a) The lack of work routines
hinders the implementation
of the recommendations
into my practice
IG +
CG
19.0
(4)
33.3
(7)
47.6
(10)
IG 10 (1) 20.0
(2)
70
(7)
CG 27.3
(3)
45.5
(5)
27.3
(3)
2 (b) The elaboration of
implementation action
plans helped to establish
routines for the
implementation of the
recommendations
IG 30.0
(3)
60.0
(6)
10.0
(1)
3 (a) It is difficult for me to
select the patients who
profit most from SMC
IG +
CG
0.0
(0)
23.8
(5)
76.2
(16)
IG 0.0
(0)
40.0
(4)
60.0
(6)
CG 0.0
(0)
9.1
(1)
90.9
(10)
3 (b) The patient list provided at
the beginning of the study
helped me to identify suitable
patients for SMC
IG 40.0
(4)
40.0
(4)
20.0
(2)
4 (a) Instruments for medication
reviews such as the PRISCUS
list or the MAI are not feasible
enough to use them regularly
IC +
CG
42.9
(9)
47.6
(10)
9.5
(2)
IG 30.0
(3)
60.0
(6)
10.0
(1)
CG 54.5
(6)
36.4
(4)
9.1
(1)
4 (b) The online-tools and checklists
provided on the tablet PC
helped me to conduct
medication reviews.
IG 50.0
(5)
30.0
(3)
20.0
(2)
5 (a) The lacking standardization
of medication lists impede
the implementation of
recommendation B into
my practice
IG +
CG
23.8
(5)
38.1
(8)
38.1
(8)
IG 20.0
(2)
40.0
(4)
40.0
(4)
CG 27.3
(3)
36.4
(4)
36.4
(4)
5 (b) The provided template for
medication lists helped me
to bring the medication list
of my practice in line with
defined minimum standards.
IG 50.0
(5)
20.0
(2)
30.0
(3)
Table 1 Survey on determinants and strategies (Continued)
6 (a) The lacking self-management
abilities of patients impede
the implementation of the
recommendations into my
practice
IG +
CG
19.0
(4)
71.4
(15)
9.5
(2)
IG 20.0
(2)
70.0
(7)
10.0
(1)
CG 18.2
(2)
72.7
(8)
9.1
(1)
6 (b) The information material
(posters, tablet pc) induced
patients to take their
medication list with them.
IG 50.0
(5)
30.0
(3)
20.0
(2)
7 (a) Language barriers of
non-German-speaking patients
impede the implementation
of recommendation A into
my practice
IG +
CG
52.4
(11)
23.8
(5)
23.8
(5)
IG 50.0
(5)
20.0
(2)
30.0
(3)
CG 54.5
(6)
27.3
(3)
18.2
(2)
7 (b) The info-tool on the tablet
PC helped to reduce problems
due to language barriers
IG 30.0
(3)
40.0
(4)
20.0
(2)
8 (a) Difficulties of comprehension
between me and my patients
impede the implementation
of recommendation A into
my practice
IG +
CG
28.6
(6)
28.6
(6)
42.9
(9)
IG 30.0
(3)
30.0
(3)
40.0
(4)
CG 27.3
(3)
37.3
(3)
45.5
(5)
8 (b) The info-tool on the tablet PC
facilitated the communication
with my patients
IG 40.0
(4)
50.0
(5)
10.0
(1)
The “(a) items” were applied to the intervention and control group; the “(b)
items” were applied to the intervention group only
IG intervention group, CG control group
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combining the findings from the different data sources
for the purpose of triangulation.
Hypothesis 1: training increased expert knowledge
and routines
The aim of the workshop offered to the practice teams
was to convey the necessary knowledge about the rec-
ommendations, to discuss possible barriers for their im-
plementation and to develop a menu of strategies the
participants could use to avoid errors and to overcome
barriers and thus to establish work routines for the rec-
ommendations in their practice. Furthermore, role plays
to practice “brown bag reviews” and case examples to
practice structured medication reviews were done. Dir-
ectly after the workshop, the participants had been asked
to complete an evaluation form on course and content
of the workshop. This evaluation was almost exclu-
sively positive [27]. In the survey conducted 9 months
after the workshop, 71% of the participants stated that
they considered the lack of knowledge at least partly a
relevant determinant and that the workshop helped to
address this determinant (Table 1, item 1). In the inter-
views conducted 9 months after the workshop, the
evaluation was more heterogeneous. Some participants
hardly remembered the content of the workshop.
While the MAs especially appreciated the group work
and the materials, GPs tended to complain about the
efforts the participation in the workshop caused. Yet,
they appreciated the exchange with colleagues and sug-
gested to integrate the training into the small group
meetings of the quality circles.
What was most helpful for me: the exchange with the
other colleagues (GP)
I would like to reinforce this in our quality circle and
discuss specific or difficult patients (GP)
Hypothesis 2: implementation action plans increased
routine
After the workshop, the practice teams were asked to
organize a team meeting and to elaborate an implemen-
tation action plan. For this purpose, they received a writ-
ten compilation of the barriers and solutions collected
during the workshop which has been published before
[27]. We asked them to send us a written report with
the following key aspects: (a) the barriers/error sources
that were most important in their specific practice, (b)
the activities they planned to overcome the barriers, (c)
the responsible person for each activity and (d) the time
schedule for each activity. The aim of this strategy was
to raise awareness for the care deficiencies and error
sources in their own practice among all practice staff
and to establish work routines for the recommendations.
In the survey, nearly half of the GPs stated that the lack
of work routines was not a relevant barrier in their practice.
However, 90% of the GPs of the intervention group found
that the elaboration of implementation action plan helped
at least partly to establish such work routines (see Table 1,
item 2). In the interviews, the participants expressed differ-
ent views on this strategy. Some GPs appreciated that the
implementation action plan helped them to raise awareness
and to motivate the practice staff for change.
This helped us a lot. The motivation of the staff was
stronger and as you can see we have realised most of
the issues we have elaborated. That was most helpful
(GP).
The essential thing is to become aware of the
difficulties (…) this is for sure what [helped] most
(GP).
On the other hand, it became clear that not all prac-
tices had elaborated their concept during a team meet-
ing, but that in some cases GPs had assigned the tasks
without asking the agreement of the MA. Some
expressed difficulties to identify room for improvement
in their practice.
All this happens already automatically in our practice
and this is why there was nothing to change (MA)
Looking at the written reports, there was substantial
variance concerning the length, the level of detail and
the readability of the specifications. The following bar-
riers/error sources were mentioned: writing prescrip-
tions, repeated prescriptions, double prescriptions,
dosing errors, complete medication not known, com-
munication problems, patients do not carry their
medication list with them, frequent change of trade
names of the medications and software errors. The ac-
tivities they decided to undertake frequently referred
to the process of issuing prescriptions, such as to write
repeated prescriptions only for medications specified
on the medication list and that the MA should ask
patients for their medication list when printing pre-
scriptions, to inform patients that the issuing of pre-
scriptions will take 1 day and to create a flyer to
encourage them to use the practice hotline for order-
ing prescriptions. Other activities they specified were
as follows: create a medication list including prescrip-
tions of other doctors, MA reminds GP of medication
lists, ask pharmacists to note down the trade name on
the medication list when issuing the medication, docu-
ment the distribution of sample packages, note down
allergies and the reason for prescription on the medi-
cation list, combine brown bag reviews with check-
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ups, draft a separate form for insulin injections, update
medication lists of nursing home patients by phone
every 3 months or during each home visit, install links
to online tools on all computers in the practice and
monitor ADR.
Hypothesis 3: patient lists helped to identify suitable
patients for SMC
We provided all practices (also the control practices) with
a list of patients meeting the inclusion criteria based on
insurance claim data to support them to identify suitable
patients for SMC. According to the survey, for the major-
ity of GPs, the identification of these patients was not a
relevant determinant (Table 1, item 3). Yet, 80% of the
GPs from the intervention group regarded the patient list
as (partly) helpful. In the interviews, however, the identifi-
cation of the target group was a frequently mentioned
issue. Some physician said they would have preferred to
include other patients than those on the list.
I can just pick patients here and then, when I have
the feeling, I should have a look here (…) But this
patient with the insulin, that was actually no risk
patient for me, he would not have struck me due to
the lab results. So the question is: How to reach
these people? That’s virtually impossible! (GP)
There were not so many news or changes in those
specific patients (…), but you are more sensitized and
you pay more attention in other patients as well (GP)
Hypothesis 4: the checklist helped to establish routines
for SMC in the practice
In the interviews, most GPs expressed a negative view of
the checklist for SMC (provided as Additional file 1), al-
though they were rather talking about checklists in gen-
eral. Many GPs stated that there were too many checklists
for too many issues which were not feasible and too time
consuming for use in practice. Furthermore, many GPs
felt that providing them with checklists was a way of ques-
tioning their experience and competence.
I think you shouldn’t try to take away someone’s
experience because of some checklist or guideline
(GP).
I need a checklist only if I don’t have knowledge (…)
you should trust the doctors more, they have
knowledge and that they don’t need checklists! (GP)
Another issue was that they feared the use of a check-
list aiming at standardizing or structuring the conversa-
tion would impede the individual care for the patient.
Some GPs mentioned that checklists might be useful for
young, unexperienced doctors. MAs were more positive
towards the checklist and stated that they would have
used it, if it would have been digital and available via the
computers in the practice.
Hypothesis 5: the aids for medication reviews increased
expert knowledge and feasibility of instruments for
systematic medication reviews
During the workshop, we introduced some aids (a
sheet with a modified MAI and the PRISCUS drugs in
alphabetic order and online resources) to the GPs
which they could use for a systematic medication re-
view (see Additional file 2). In the survey, the vast ma-
jority of GPs stated that such tools were generally not
feasible enough to use them regularly but the majority
of the GPs of the intervention group considered the
provided materials helpful for medication reviews
(Table 1, item 4). In the interviews, the main barrier
for using the tools was that they were not integrated
into the practice software. One GP stated to have
added the links to the online resources to the favour-
ites bar of each computer in the practice.
No, we didn’t use the tablet very much. If I go online,
I do it with [my computer] (…) so we didn’t use it (…)
because [these tools] were disconnected from our
system (GP).
Hypothesis 6: the template helped to bring medication lists
in line with the standards
Medication lists frequently lack important information.
We provided the practice teams with a template defining
the minimum standards for a comprehensive medication
list (e.g. that the list should contain the name of the ac-
tive ingredient and not only trade names and the reason
for drug use) and asked them to bring the medication
lists they are using in line with those standards. In the
survey (Table 1, item 5), about 60% of the GPs consid-
ered the lack of standards for medication lists a relevant
barrier and 70% stated that the template was helpful to
adjust the medication lists used in their practices. In the
interviews, many respondents reported to add the reason
for prescription more often now.
The analysis of the primary outcome, however,
showed that GPs rarely made any changes concerning
the layout and content of their medication lists [28].
In the interviews and in the implementation action
plans, it became evident that two major barriers for
bringing the medication lists in line with the template
had not been addressed. The first one was the func-
tions of the practice software which frequently did not
allow easy adjustment of the medication list template.
The second was partial disagreement with the recom-
mendation (see hypothesis 9).
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That’s a problem of the system, we cannot
simply change this (…). That’s beyond our
possibilities (GP).
Hypothesis 7: the information material for patients
increased the self-management abilities of patients and
reduced language barriers and difficulties of
comprehension
We developed various materials to sensitize patients
for medication-related issues in order to increase pa-
tients’ self-management abilities and to address lan-
guage barriers and difficulties of comprehension. A
multilingual info-tool on the tablet PC was provided
to the practices, focusing on the importance of a
comprehensive medication list and safe medication
use as well as posters calling upon patients to always
have their medication list with them and brown
paper bags with an imprint encouraging patients to
bring their medication packages to the appointment
for SMC.
In the survey, 90% of the GPs agreed that patients’
self-management abilities were a relevant determinant
and 76% did so concerning the language barrier. Diffi-
culties of comprehension were not considered a
relevant determinant by 43% of GPs. The question
whether these determinants had been successfully modi-
fied by the provided materials was affirmed by 80% of GPs
regarding the self-management abilities, by 70% regarding
the language barrier and by 90% regarding the difficulties
of comprehension (Table 1, item 6–8).
The interview statements were in line with these sur-
vey findings concerning the posters and the brown bag,
but contradictory concerning the info-tool on the tablet.
While most interviewees found the posters and paper
bags useful, they reported many problems with the use
of the info-tool on the tablet PC mainly because of prob-
lems with the internet connection and the suitability for
elderly patients.
I think mainly the posters, that they should
always have their medication list with them,
maybe this sensitised them [the patients]. That
was good! (MA)
Almost none of our patients was able to use this
tablet themselves. I think the medical assistant did
it with them and read it to them or showed it to
them (GP)
The analysis of the log file showed logins for 49 differ-
ent patients (34.3% of the patients of the intervention
group). The tool was used 11 times in Turkish. The
average login time was 5.9 (0.5–34.7) minutes.
Hypothesis 8: implementation of the recommendations
has improved
When asking the participants what effect the study had on
the processes in their practice, they frequently answered
that it had increased their awareness and that they adhered
to the recommendations more consistently than before.
It’s not that we have not done this before. We have
always done this in patients with dementia or when
other problems played a role and when we believed
that something is going wrong. But I think we will do
it more often in the future (GP).
Of course it is our job to take care that the medications
fit and so on. But due to the study I was sensitised to do
this more often. And in that respect it helped me (GP).
Some MAs also reported that the study had led to a
change of the roles and tasks of the practice staff which
is also a hint that implementation of the recommenda-
tion has increased in the practice.
We ask more about it and are more interested in it.
Before it was only the problem of the doctor and now
we do it as well (MA)
Some reported to combine the recommendations now
regularly with already established treatment programmes
such as disease management programmes or yearly
check-ups.
We made it a rule – based on the experience – to let
[patients] bring their medications for the DMPs (…).
Because you saw how necessary it is and, yes, how
many dangerous things happen as well, I think (GP).
The risk patients come any way, at least once per year
for the check-up (…) and I think you can combine
this very well (…). The only thing is that we, the
assistants, have to accustom ourselves to telling the
patients, when they make an appointment: Bring your
medications with you! (MA)
I think we will adopt this to 100%, mainly the thing
with the check-ups, when patients come anyway (MA).
Another positive issue which was mentioned repeat-
edly was that the patients’ use of their medication list
had improved.
The patients made more efforts to understand and
update their medication list. This did a lot for us (…),
that was surprisingly positive. I wouldn’t have thought
this, to be honest. (GP)
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I think the patients take it more serious now, that
they carry the medication list with them (MA)
I think many became aware what it means to have a
medication list and to show it to everyone (GP).
Hypothesis 9: the implementation of the recommendations
leads to improved health outcomes
We did not examine health outcomes such as hospitalization
or mortality in the trial but assumed that the implementation
of evidence-based recommendations will lead to improved
health outcomes. Yet, an indication of the usefulness of the
recommendations can be derived from the available data.
The GPs (n= 8) documented in total 116 appointments for
SMC, 99 brown bag reviews and 107 medication reviews
(Table 2). According to this documentation, about half of the
patients required information and in 43% of the cases, the
GPs received useful information during the appointment for
structured medication counselling. Irregularities during the
brown bag review and a change of the medication were doc-
umented for 20% of the cases.
In the interviews, the respondents mentioned both
negative and positive aspects of the recommendations:
They expected that medication reviews would help to re-
duce polypharmacy and to avoid ADR but also found it
time consuming and only necessary for specific patients.
They agreed that the medication list is an important
instrument for communication mainly among doctors
(less for the patients), but some also stated that in their
opinion, it was not necessary that patients carry the
medication list with them as it was saved in the practice
computer and many preferred less or different informa-
tion on the medication list than the minimum standards
defined by the template to keep it “simple and clear”.
Concerning structured medication counselling, they
appreciated the gain of information, the improvement of
the doctor-patient relationship, the sensitization of the
patients and the saving in time due to the structured
process. Yet, they also thought that a separate appointment
for structured medication counselling was not necessary as
the targeted patients already visit the practice frequently
and talking about medication is already something they do,
even if not in such a structured way. Some expressed fears
to unsettle patients by giving too much information.
Many patients are unsettled, even by the package
insert (…) The patients are not able to understand
all this (…) you weigh up, how is the benefit and then
we make the decision. But I take the decision and we
don’t know if there will be a side effect, but they have
to trust me that the medication is right for them.
They are not able to understand all this, I don’t even
know if they understand me. If I would list all side
effects (…) they would be very concerned (GP).
One interviewee expressed doubts about the evidence
and the effect of the recommendations.
This is my next question: What’s the point of it?
What do you want to reach? That less patients die
from side effects or what? (…) Of course we are
interested in treating our patients better, but to talk
about medication just like this? (…). Is there any
statistical prove that more patients become sick from
drug administration? Is this certain? I can’t judge this.
(GP).
Discussion
Systematic reviews on interventions to improve poly-
pharmacy frequently come to the conclusion that the ef-
fects of the interventions are variable and conflicting
[14, 33–36]. In the logic of “tailoring”, the effectiveness
of implementation strategies will increase if the barriers
for adopting the desired behaviour are overcome or fa-
cilitating factors are used appropriately. This process
evaluation aimed to explain the low effectiveness of a
tailored programme. From the results, several sugges-
tions for modification of the TP can be derived which
we describe below in accordance with the “framework
and coding system for modifications and adaptations of
evidence-based interventions” published by Stirman et
al. It distinguishes the following key questions: By whom
is what (content, context or evaluation) at what level of
delivery modified and what is the nature of content mod-
ifications [17]?
By whom are modifications made?
The modifications reported in this article are suggestions
of the researcher who designed and evaluated the TP.
Modifications of context and level of delivery
Bringing medication lists in line with minimum stan-
dards failed among others, because the necessary soft-
ware functions were not provided due to limited
resources of the trial. In Germany, this barrier is cur-
rently being addressed by a nation-wide project which
aims at implementing a standardized medication list in
Germany [37]. The perspective of this change in the
health care system might have influenced the target
group’s motivation of making changes themselves and
should have been respected by the TP.
Concerning the quality of the written reports on the
implementation action plans, it became apparent that
more guidance for this process is needed. This could be
realized by conducting outreach visits instead of a work-
shop. Outreach visits could reduce the efforts for partici-
pation in the training and guidance for the analysis of
the individual barriers and the elaboration of the imple-
mentation action plans could be offered e.g. by defining
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standard operating procedures for medication manage-
ment in primary care practices.
Modification of content by integrating the intervention
into another approach
There is evidence that outreach visits are an effective
educational strategy [38]; however, large-scale imple-
mentation of outreach visits is resource intensive but
could be integrated in quality management systems,
which are obligatory in Germany, such as the “European
practice assessment” [39].
Modification of content by lengthening and extending
elements
Targeting patients who profit most from intensified care
was another aspect of the intervention which ought to
be improved. We tried to support this process by analyz-
ing insurance claim data and by the individual assess-
ment of the patients by the GPs. Yet, time-consuming
procedures such as the brown bag review and systematic
medication reviews resulted in only 20% of the cases in
an actual change of the medication; a benefit concerning
information exchange was perceived in 31–43% of the
cases. The barrier of defining the target group has been
identified in similar studies [40], so future research
should focus on the development of methods for target-
ing or tailoring interventions on a more individual level.
Modification of content by adding elements
The determinants we intended to modify are similar to
those targeted in comparable studies, such as routine,
knowledge or professional communication [6, 41], and
also the strategies used in other TPs focusing on poly-
pharmacy, e.g. academic detailing, education, treatment
algorithms, patient information leaflets and paper bags,
are similar to the strategies we selected [42, 43]. How-
ever, we did not involve pharmacists, a frequently used
strategy to improve prescribing with variable effects [13],
and did not address barriers related to inter-professional
and inter-sectoral collaboration. These barriers are cer-
tainly of relevance in multimorbid patients with poly-
pharmacy, but difficult to modify with the resources we
had in our project. It would be desirable that future re-
search projects with adequate funds focus on such
aspects.
Modification of content by loosening structure
The interviews showed that not all participants were com-
pletely convinced about the purpose of the evidence-based
recommendations which might be related to insufficient
targeting, because an added benefit of adhering to the rec-
ommendations was only evident for particular patients.
But also the nature of the recommendations, which all
comprised a certain standardization and structuring of
care processes, may have provoked resistance, because
Table 2 Documentation of structured medication counselling and medication reviews
Yes
% (n)*
No
% (n)*
1. Did you conduct structured medication counselling with this patient? 96.7 (116) 3.3 (4)
1.1 If yes, did the patient require any information? 53.4 (62) 46.5 (54)
1.2 If yes, did you receive any useful information from the patient or his/her relatives? 43.1 (50) 56.9 (66)
2. Did you conduct a complete inventory of the medication actually taken by the patient (“brown bag review”)? 82.5 (99) 17.5 (21)
2.1 If yes, did the patient bring his medication packages to the practice for this purpose? 74.7 (74) 25.3 (25)
2.2 If yes, were there any irregularities? 20.2 (20) 29.8 (79)
2.3 If yes, did you receive useful information due to the “brown bag review”? 31.3 (31) 67.7 (67)
2.4 If yes, did the brown bag review result in useful instructions for the patient? 43.4 (43) 56.6 (56)
3. Did you give the patient an updated medication list at the end of the appointment? 84.2 (101) 15.8 (19)
4. Did you review the medication of the patient systematically? 89.2 (107) 10.8 (13)
4.1 If yes, did you use the checklist for medication reviews provided by the study? 59.8 (64) 40.2 (43)
4.2 Did you use any other instrument for the medication review? 17.8 (19) 82.2 (88)
4.3 Did the medication review result in a change of the medication? 21.5 (23) 78.5 (84
4.4 If yes, what changes did you make?
Stopping a medication 34.8 (8)
Prescription of a new drug 30.4 (7)
Change of the dosis 47.8 (11)
Change of application 0.0
Other 13.0 (3)
*Percentages refer to 120 medication counselling sessions documented by 8 GPs
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principles of evidence-based medicine (EBM) are some-
times difficult to apply to highly complex patients. While
EBM “tends to depict the patient’s illness as a fixed entity
with more or less stables properties” [44] and as a conse-
quence tries to define standard treatments for standard
situations, several statements indicate that the inter-
viewees were reluctant to standardizing care in this patient
group, e.g. to using checklists or to structuring consulta-
tions—a view that is supported by parts of the scientific
community. For instance, Greenhalgh et al. point out that
“evidence-based discussions about options for tests and
treatments rarely take full account of which people and
perspective the patient would like to bring into the dis-
cussion” [44]. From our perspective, this view points
out the misunderstanding that standardizing care pro-
cesses are equivalent with standardizing the content of
care. Clinical experience and patient preferences are
crucial in an EBM approach. The recommendations we
chose make suggestions on process level to ensure that
there is room for communication, documentation and
critical review of medications and that treatment deci-
sion is based on a thorough analysis of the individual
situation, needs and preferences of the patient. They do
not imply any specific treatment recommendations, just
as “shared decision making” does not mean that every
patient under any circumstances has to be involved into
decision making. It is well known that some patients
prefer to hand over responsibilities in a rather patri-
archic patient-physician relationship. In such a case,
“shared decision making” can result into the decision
not to provide further information. As a consequence, a
critical discussion with the target group about the pur-
pose of evidence-based recommendations and the
intention behind structuring care processes should be
part of implementation processes.
Modification of content by tailoring
The educational material for patients was generally con-
sidered useful but could have been improved by offering
different formats for different target groups, e.g. pam-
phlets additionally to the electronical info-tool or differ-
ent sizes of the posters. There is evidence that tailored
educational material is in some cases superior to non-
tailored formats [45].
Modification of evaluation
The raise of awareness was the most frequently
mentioned effect of the TP. Several theories state
that “becoming aware” is the first necessary step of
behaviour change (compare Fig. 2). Although we
tried to induce the subsequent steps of behaviour
change by the elaboration of the implementation ac-
tion plans, it is possible that we did not observe a
measurable improvement of implementation because
the follow-up time was too short and more time for
behaviour change was needed. On the other hand,
some interviewees reported to have integrated struc-
tured medication counselling into existing routine
procedures, so they reported “habitual behaviour”.
This is in line with the analysis of the primary out-
come which showed a positive effect only for medi-
cation counselling [28].
Limitations
Some limitations of this study have to be taken into ac-
count: Comparing the findings from the different data
sources we used, it was striking that 70–90% of the GPs
affirmed the usefulness of all strategies, even when de-
terminants were considered not relevant by the majority
of the respondents. Thus, the informative value of the
survey is limited, also due to the small number of GPs
completing the survey. In the interviews, heterogeneous
views on the strategies and determinants were found.
Some determinants were perceived as irrelevant and
Fig. 2 Behaviour change model according to [46]
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some strategies as not useful by a considerable number
of health care professionals leading to the questions
whether the methods used to identify determinants and
strategies were appropriate and effective. For example, it
is possible that involving the target group into the final
selection of determinants and strategies could have in-
creased the perceived relevance and acceptance. This as-
pect has been examined in an international process
evaluation combining the findings from the five TICD
trials [43].
Conclusions
While most of the hypotheses specified by the logic
model of the TP were confirmed by the survey, the
combination of qualitative and quantitative methods re-
sulted in a more detailed understanding of the target
group’s view on the TP and the recommendations. It
seemed that the TP had successfully induced the first
step of behaviour change which is raising awareness
while habitual behaviour was reported for only one of
the recommendations. Several suggestions for modifica-
tion of the TP could be deduced, such as conducting
outreach visits instead of a workshop, improved target-
ing, provision of evidence, integration of tools into the
practice software and the creation of information mate-
rials in tailored formats.
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